camptothecin has been researched along with parthenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandey, AH; Chashoo, G; Mondhe, D; Qazi, GN; Qazi, NA; Reddy, DM; Sampath Kumar, HM; Sawant, SD; Saxena, A; Saxena, AK; Sethi, VK; Shankar, M; Singh, SK; Srinivas, J; Taneja, SC; Verma, M | 1 |
| Alam, MS; Chasoo, G; Gayatri, JL; Hyder, I; Khazir, J; Mahajan, A; Nalla, N; Prasad Yandrati, L; Qazi, GN; Sampath Kumar, HM; Saxena, AK | 1 |
2 other study(ies) available for camptothecin and parthenin
| Article | Year |
|---|---|
Design and synthesis of spiro derivatives of parthenin as novel anti-cancer agents.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; DNA Fragmentation; Humans; Male; Mice; Neoplasm Transplantation; NF-kappa B; Nitriles; Oxides; Prostatic Neoplasms; Sesquiterpenes; Spiro Compounds; Structure-Activity Relationship | 2011 |
Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Topics: Antineoplastic Agents; Azulenes; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Molecular Structure; Sesquiterpenes; Structure-Activity Relationship; Triazoles | 2014 |